Selected research
Market Structure
Global Glass Vial for Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Glass Vial for Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Glass Vial for Vaccine include Schott AG, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma and Piramal Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Glass Vial for Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glass Vial for Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glass Vial for Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glass Vial for Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.
Glass Vial for Vaccine Segment by Company
Schott AG
DWK Life Sciences
Richland Glass
Nipro
Pacific Vial Manufacturing
Origin Ltd
Stevanato Group
SGD Pharma
Piramal Glass
Zheng Chuan
Shandong Pharmaceutical Glass
Zheng Li
Gerresheimer
Four Stars Glass
JOTOP Glass
Glass Vial for Vaccine Segment by Type
Molded Glass Vial
Tubular Glass Vial
Glass Vial for Vaccine Segment by Application
Preventive Vaccine
Therapeutic Vaccine
Glass Vial for Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glass Vial for Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glass Vial for Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glass Vial for Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glass Vial for Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glass Vial for Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glass Vial for Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Glass Vial for Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Molded Glass Vial
- Tubular Glass Vial
Applications
- Preventive Vaccine
- Therapeutic Vaccine
Companies covered
- Schott AG
- DWK Life Sciences
- Richland Glass
- Nipro
- Pacific Vial Manufacturing
- Origin Ltd
- Stevanato Group
- SGD Pharma
- Piramal Glass
- Zheng Chuan
- Shandong Pharmaceutical Glass
- Zheng Li
- Gerresheimer
- Four Stars Glass
- JOTOP Glass
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Glass Vial for Vaccine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Glass Vial for Vaccine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Glass Vial for Vaccine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Glass Vial for Vaccine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Glass Vial for Vaccine Market Dynamics
- 2.1 Glass Vial for Vaccine Industry Trends
- 2.2 Glass Vial for Vaccine Industry Drivers
- 2.3 Glass Vial for Vaccine Industry Opportunities and Challenges
- 2.4 Glass Vial for Vaccine Industry Restraints
3 Glass Vial for Vaccine Market by Manufacturers
- 3.1 Global Glass Vial for Vaccine Revenue by Manufacturers (2021-2026)
- 3.2 Global Glass Vial for Vaccine Sales by Manufacturers (2021-2026)
- 3.3 Global Glass Vial for Vaccine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Glass Vial for Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glass Vial for Vaccine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Glass Vial for Vaccine Manufacturers, Product Type & Application
- 3.7 Global Glass Vial for Vaccine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glass Vial for Vaccine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glass Vial for Vaccine Players Market Share by Revenue in 2025
- 3.8.3 2025 Glass Vial for Vaccine Tier 1, Tier 2, and Tier 3
4 Glass Vial for Vaccine Market by Type
- 4.1 Glass Vial for Vaccine Type Introduction
- 4.1.1 Molded Glass Vial
- 4.1.2 Tubular Glass Vial
- 4.2 Global Glass Vial for Vaccine Sales by Type
- 4.2.1 Global Glass Vial for Vaccine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glass Vial for Vaccine Sales by Type (2021-2032)
- 4.2.3 Global Glass Vial for Vaccine Sales Market Share by Type (2021-2032)
- 4.3 Global Glass Vial for Vaccine Revenue by Type
- 4.3.1 Global Glass Vial for Vaccine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glass Vial for Vaccine Revenue by Type (2021-2032)
- 4.3.3 Global Glass Vial for Vaccine Revenue Market Share by Type (2021-2032)
5 Glass Vial for Vaccine Market by Application
- 5.1 Glass Vial for Vaccine Application Introduction
- 5.1.1 Preventive Vaccine
- 5.1.2 Therapeutic Vaccine
- 5.2 Global Glass Vial for Vaccine Sales by Application
- 5.2.1 Global Glass Vial for Vaccine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glass Vial for Vaccine Sales by Application (2021-2032)
- 5.2.3 Global Glass Vial for Vaccine Sales Market Share by Application (2021-2032)
- 5.3 Global Glass Vial for Vaccine Revenue by Application
- 5.3.1 Global Glass Vial for Vaccine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glass Vial for Vaccine Revenue by Application (2021-2032)
- 5.3.3 Global Glass Vial for Vaccine Revenue Market Share by Application (2021-2032)
6 Global Glass Vial for Vaccine Sales by Region
- 6.1 Global Glass Vial for Vaccine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glass Vial for Vaccine Sales by Region (2021-2032)
- 6.2.1 Global Glass Vial for Vaccine Sales by Region (2021-2026)
- 6.2.2 Global Glass Vial for Vaccine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Glass Vial for Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Glass Vial for Vaccine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Glass Vial for Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Glass Vial for Vaccine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Glass Vial for Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Glass Vial for Vaccine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Glass Vial for Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Glass Vial for Vaccine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Glass Vial for Vaccine Revenue by Region
- 7.1 Global Glass Vial for Vaccine Revenue by Region
- 7.1.1 Global Glass Vial for Vaccine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Glass Vial for Vaccine Revenue by Region (2021-2026)
- 7.1.3 Global Glass Vial for Vaccine Revenue by Region (2027-2032)
- 7.1.4 Global Glass Vial for Vaccine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Glass Vial for Vaccine Revenue (2021-2032)
- 7.2.2 North America Glass Vial for Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Glass Vial for Vaccine Revenue (2021-2032)
- 7.3.2 Europe Glass Vial for Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Glass Vial for Vaccine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Glass Vial for Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Glass Vial for Vaccine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Glass Vial for Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Schott AG
- 8.1.1 Schott AG Company Information
- 8.1.2 Schott AG Business Overview
- 8.1.3 Schott AG Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Schott AG Glass Vial for Vaccine Product Portfolio
- 8.1.5 Schott AG Recent Developments
- 8.2 DWK Life Sciences
- 8.2.1 DWK Life Sciences Company Information
- 8.2.2 DWK Life Sciences Business Overview
- 8.2.3 DWK Life Sciences Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 DWK Life Sciences Glass Vial for Vaccine Product Portfolio
- 8.2.5 DWK Life Sciences Recent Developments
- 8.3 Richland Glass
- 8.3.1 Richland Glass Company Information
- 8.3.2 Richland Glass Business Overview
- 8.3.3 Richland Glass Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Richland Glass Glass Vial for Vaccine Product Portfolio
- 8.3.5 Richland Glass Recent Developments
- 8.4 Nipro
- 8.4.1 Nipro Company Information
- 8.4.2 Nipro Business Overview
- 8.4.3 Nipro Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Nipro Glass Vial for Vaccine Product Portfolio
- 8.4.5 Nipro Recent Developments
- 8.5 Pacific Vial Manufacturing
- 8.5.1 Pacific Vial Manufacturing Company Information
- 8.5.2 Pacific Vial Manufacturing Business Overview
- 8.5.3 Pacific Vial Manufacturing Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pacific Vial Manufacturing Glass Vial for Vaccine Product Portfolio
- 8.5.5 Pacific Vial Manufacturing Recent Developments
- 8.6 Origin Ltd
- 8.6.1 Origin Ltd Company Information
- 8.6.2 Origin Ltd Business Overview
- 8.6.3 Origin Ltd Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Origin Ltd Glass Vial for Vaccine Product Portfolio
- 8.6.5 Origin Ltd Recent Developments
- 8.7 Stevanato Group
- 8.7.1 Stevanato Group Company Information
- 8.7.2 Stevanato Group Business Overview
- 8.7.3 Stevanato Group Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Stevanato Group Glass Vial for Vaccine Product Portfolio
- 8.7.5 Stevanato Group Recent Developments
- 8.8 SGD Pharma
- 8.8.1 SGD Pharma Company Information
- 8.8.2 SGD Pharma Business Overview
- 8.8.3 SGD Pharma Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 SGD Pharma Glass Vial for Vaccine Product Portfolio
- 8.8.5 SGD Pharma Recent Developments
- 8.9 Piramal Glass
- 8.9.1 Piramal Glass Company Information
- 8.9.2 Piramal Glass Business Overview
- 8.9.3 Piramal Glass Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Piramal Glass Glass Vial for Vaccine Product Portfolio
- 8.9.5 Piramal Glass Recent Developments
- 8.10 Zheng Chuan
- 8.10.1 Zheng Chuan Company Information
- 8.10.2 Zheng Chuan Business Overview
- 8.10.3 Zheng Chuan Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zheng Chuan Glass Vial for Vaccine Product Portfolio
- 8.10.5 Zheng Chuan Recent Developments
- 8.11 Shandong Pharmaceutical Glass
- 8.11.1 Shandong Pharmaceutical Glass Company Information
- 8.11.2 Shandong Pharmaceutical Glass Business Overview
- 8.11.3 Shandong Pharmaceutical Glass Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Shandong Pharmaceutical Glass Glass Vial for Vaccine Product Portfolio
- 8.11.5 Shandong Pharmaceutical Glass Recent Developments
- 8.12 Zheng Li
- 8.12.1 Zheng Li Company Information
- 8.12.2 Zheng Li Business Overview
- 8.12.3 Zheng Li Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Zheng Li Glass Vial for Vaccine Product Portfolio
- 8.12.5 Zheng Li Recent Developments
- 8.13 Gerresheimer
- 8.13.1 Gerresheimer Company Information
- 8.13.2 Gerresheimer Business Overview
- 8.13.3 Gerresheimer Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Gerresheimer Glass Vial for Vaccine Product Portfolio
- 8.13.5 Gerresheimer Recent Developments
- 8.14 Four Stars Glass
- 8.14.1 Four Stars Glass Company Information
- 8.14.2 Four Stars Glass Business Overview
- 8.14.3 Four Stars Glass Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Four Stars Glass Glass Vial for Vaccine Product Portfolio
- 8.14.5 Four Stars Glass Recent Developments
- 8.15 JOTOP Glass
- 8.15.1 JOTOP Glass Company Information
- 8.15.2 JOTOP Glass Business Overview
- 8.15.3 JOTOP Glass Glass Vial for Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 JOTOP Glass Glass Vial for Vaccine Product Portfolio
- 8.15.5 JOTOP Glass Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glass Vial for Vaccine Value Chain Analysis
- 9.1.1 Glass Vial for Vaccine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glass Vial for Vaccine Production Mode & Process
- 9.2 Glass Vial for Vaccine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glass Vial for Vaccine Distributors
- 9.2.3 Glass Vial for Vaccine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst